speb/financial-data huggingface dataset:
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 10409590000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 19101900000.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 850000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1012250000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 1436580000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 277023813.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 277023813.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -83790000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
LXCHEM.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: -5260000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 19066750000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 19066750000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 19058280000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 19058280000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 10512586.42
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 470190000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -85190000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.29
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
LXCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -255350000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 30445830000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 30445830000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 19491750000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 19491750000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2575580000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2575580000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 19070160000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 19070160000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 28023700000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 6902040000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 11375670000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11375670000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 16338600000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 16338600000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 851450000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 851450000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 1990000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 348310000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 348310000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 35890000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 35890000.00
LXCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 117840000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 117840000.00
LXCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 3583010000.00
LXCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 3583010000.00
LXCHEM.NS income_statement (annual, 2025-03-31) — Write Off: 20000000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1999590000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 6929300000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 277805195.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.77
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 4793670000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 171490000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 171490000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 281460526.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.76
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 191110000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 362600000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 2135630000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 49210000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 49210000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -49210000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -49210000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 362600000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 213910000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 136040000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 6929300000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 55070000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1419180000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 141900000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 4793670000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 171490000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: -72010000.00
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
LXCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 6793260000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 2144850000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 7186820000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 276141304.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.92
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4747410000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 204700000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 204700000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 276141304.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.92
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 326060000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 530760000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 2439410000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 67960000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 67960000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -67960000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -67960000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 530760000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 254050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 294560000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 7186820000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 31500000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1441380000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 258100000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4747410000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 204700000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 4050000.00
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
LXCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 6892260000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 6867490000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2128470000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 27706790000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 7353100000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 7302180000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 7302180000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 5235540000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5235540000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -6033790000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -6033790000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 7957880000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7957880000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -74020000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -74020000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Amortization: 2270000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 2270000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 257770000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 257770000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 277147873.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.77
LXCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 416370000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 3853060000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 3853060000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -6024540000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -6024540000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 22020000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 22020000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 554300000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 554300000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 601380000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 601380000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 943280000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 943280000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -138530000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 601380000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 601380000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 150030000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -309970000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 43240000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 475860000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 189380000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 578840000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 185010000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 554300000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 554300000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -138530000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 19855950000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 19855950000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 4720000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 6622500000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 6622500000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 19729060000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4880300000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 12613280000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 12613280000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 8020000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 8020000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 476650000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 476650000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 484670000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 484670000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 412570000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 412570000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 9266870000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 9266870000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 63150000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 63150000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 764080000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 766350000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 766350000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 191980000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 764080000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 191980000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 277147873.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.77
LXCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — EBIT: 1098800000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 371470000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 1865150000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 563450000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 601380000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2472180000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 929120000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 929120000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -4275570000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -69840000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 8080000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 495790000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 7800000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 7800000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 5309560000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 5309560000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 27455020000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 27455020000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 7977730000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 2472800000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 219090000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 46750000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 219090000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 46750000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Interest Income: 25010000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 25010000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -257350000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 57260000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 3651310000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3651310000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 25264180000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 25264180000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4036140000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 257770000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 257770000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 27620000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 4720000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 5000000000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 1816640000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1816640000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 14000000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 14000000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 4931580000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4931580000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4945580000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4945580000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 5000000000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -257890000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 27620000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 96510000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 96510000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 15140510000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 15140510000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 3410000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 3410000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 4720000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 4806850000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 4806850000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 5090000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 215510000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 879710000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 793620000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 215510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -195870000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -46750000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 1930170000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 2876520000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 4742110000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -195870000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -46750000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 748300000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 21421230000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 21421230000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 970000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -1865590000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 19848150000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 19848150000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 26150000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 26150000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 289510000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 289510000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 96510000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 96510000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 209980000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 209980000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1789000000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 563450000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 724922175.72
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 215510000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1748970000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 1110240000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 344330000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 27706790000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 7353100000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 277147873.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 277147873.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2467680000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2467680000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 60290000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 60290000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 162120000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 162120000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 7800000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 7800000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 24090000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 24090000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -48450000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -10000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -10000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 3530000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 27140000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 3789060000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1582790000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 744870000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 744870000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 22310000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 326480000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 326480000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 341900000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 341900000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Other Special Charges: -12510000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 8047050000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 8047050000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 2444760000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2444760000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: 879710000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 324720000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -387220000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -16331210000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 2673750000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2673750000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 19729060000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4880300000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 766350000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 191980000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 6970000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 6970000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -257890000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 11910000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 11910000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 11059210000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 11059210000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 18261380000.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 970000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 701070000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1196860000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 277147873.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 277147873.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 6310000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
LXCHEM.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 110820000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 19855950000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 19855950000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 19848150000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 19848150000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 7452175.72
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Tax Provision: 86090000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 109210000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.10
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.34
LXCHEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -94410000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 34457830000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 34457830000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 24787530000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 24787530000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 5430250000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 5430250000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 19859360000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 19859360000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 26596550000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 7008770000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 14598470000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 14598470000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 21844550000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 21844550000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5331600000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5331600000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 1790000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 412570000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 412570000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 76150000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 76150000.00
LXCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 0.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 0.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 24350000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 24350000.00
LXCHEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 3346410000.00
LXCHEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 3346410000.00
LXCHEM.NS income_statement (annual, 2026-03-31) — Write Off: 6200000.00
LXEH balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
LXEH income_statement (annual, 2021-12-31) — Basic Average Shares: 66667.00
LXEH income_statement (annual, 2021-12-31) — Basic EPS: -3657.28
LXEH balance_sheet (annual, 2021-12-31) — Cash Financial: 199411823.00
LXEH income_statement (annual, 2021-12-31) — Diluted Average Shares: 66667.00
LXEH income_statement (annual, 2021-12-31) — Diluted EPS: -3657.28
LXEH cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -2823630.00
LXEH cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 23884.00
LXEH balance_sheet (annual, 2021-12-31) — Goodwill: 26644407.00
LXEH balance_sheet (annual, 2021-12-31) — Inventory: 227600.00
LXEH balance_sheet (annual, 2021-12-31) — Liabilities Heldfor Sale Non Current: 0.00
LXEH cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -12188781.00
LXEH balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 2893183.00
LXEH balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 2893183.00
LXEH cash_flow (annual, 2021-12-31) — Operating Gains Losses: -2799746.00
LXEH cash_flow (annual, 2021-12-31) — Other Non Cash Items: 244068780.00
LXEH income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
LXEH cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
LXEH income_statement (annual, 2022-12-31) — +Operating Expense: 27726176.00
LXEH income_statement (annual, 2022-12-31) — +Total Revenue: 41353741.00
LXEH balance_sheet (annual, 2022-12-31) — Accounts Payable: 2529058.00
LXEH balance_sheet (annual, 2022-12-31) — Accounts Receivable: 4000.00
LXEH balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -37826114.00
LXEH balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 305460907.00
LXEH cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 982374.00
LXEH cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 982374.00
LXEH cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 18842000.00
LXEH balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 6609704.00
LXEH income_statement (annual, 2022-12-31) — Basic Average Shares: 66667.00
LXEH income_statement (annual, 2022-12-31) — Basic EPS: -12000.00
LXEH cash_flow (annual, 2022-12-31) — Beginning Cash Position: 199411823.00
LXEH balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 184813833.00
LXEH cash_flow (annual, 2022-12-31) — Capital Expenditure: -1296464.00
LXEH balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 7425290.00
LXEH balance_sheet (annual, 2022-12-31) — Capital Stock: 45198.00
LXEH balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 246270442.00
LXEH balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 246270442.00
LXEH balance_sheet (annual, 2022-12-31) — Cash Financial: 246761548.00
LXEH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -11400000.00
LXEH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1140005.00
LXEH cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 41341468.00
LXEH cash_flow (annual, 2022-12-31) — Cash From Discontinued Financing Activities: 181250.00
LXEH cash_flow (annual, 2022-12-31) — Cash From Discontinued Investing Activities: 683624.00
LXEH cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: -373767.00
LXEH cash_flow (annual, 2022-12-31) — Change In Account Payable: -3633087.00
LXEH cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -4841370.00
LXEH cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 194290.00
LXEH cash_flow (annual, 2022-12-31) — Change In Inventory: -936176.00
LXEH cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 0.00
LXEH cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -3880445.00
LXEH cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 2439070.00
LXEH cash_flow (annual, 2022-12-31) — Change In Payable: -3281948.00
LXEH cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -8123318.00
LXEH cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -419634.00
LXEH cash_flow (annual, 2022-12-31) — Change In Receivables: 54586398.00
LXEH cash_flow (annual, 2022-12-31) — Change In Tax Payable: 194290.00
LXEH cash_flow (annual, 2022-12-31) — Change In Working Capital: 43665895.00
LXEH cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -4000.00
LXEH cash_flow (annual, 2022-12-31) — Changes In Cash: 29292570.00
LXEH balance_sheet (annual, 2022-12-31) — Common Stock: 45198.00
LXEH balance_sheet (annual, 2022-12-31) — Common Stock Equity: 252942136.00
LXEH cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
LXEH income_statement (annual, 2022-12-31) — Cost Of Revenue: 40404962.00
LXEH balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 874894.00
LXEH balance_sheet (annual, 2022-12-31) — Current Assets: 329554088.00
LXEH balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 3866910.00
LXEH balance_sheet (annual, 2022-12-31) — Current Debt: 63500000.00
LXEH balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 67366910.00
LXEH balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 9699915.00
LXEH balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 9699915.00
LXEH balance_sheet (annual, 2022-12-31) — Current Liabilities: 134094494.00
LXEH cash_flow (annual, 2022-12-31) — Deferred Income Tax: -10273.00
LXEH cash_flow (annual, 2022-12-31) — Deferred Tax: -10273.00
LXEH cash_flow (annual, 2022-12-31) — Depreciation: 10631241.00
LXEH cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 11613615.00
LXEH cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 11613615.00
LXEH income_statement (annual, 2022-12-31) — Diluted Average Shares: 66667.00
LXEH income_statement (annual, 2022-12-31) — Diluted EPS: -12000.00
LXEH income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -7789861.00
LXEH balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 0.00
LXEH balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 23908306.00
LXEH balance_sheet (annual, 2022-12-31) — Dueto Related Parties Non Current: 216176563.00
LXEH income_statement (annual, 2022-12-31) — EBIT: -5856964.00
LXEH income_statement (annual, 2022-12-31) — EBITDA: 5756651.00
LXEH cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 18057155.00
LXEH cash_flow (annual, 2022-12-31) — End Cash Position: 246761548.00
LXEH cash_flow (annual, 2022-12-31) — Financing Cash Flow: -11218750.00
LXEH cash_flow (annual, 2022-12-31) — Free Cash Flow: 39671237.00
LXEH cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
LXEH cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
LXEH balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 65716190.00
LXEH income_statement (annual, 2022-12-31) — General And Administrative Expense: 27664531.00
LXEH balance_sheet (annual, 2022-12-31) — Goodwill: 70369837.00
LXEH balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 106409426.00
LXEH balance_sheet (annual, 2022-12-31) — Gross PPE: 205515759.00
LXEH income_statement (annual, 2022-12-31) — Gross Profit: 948779.00
LXEH income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 18842000.00
LXEH cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 935716.00
LXEH balance_sheet (annual, 2022-12-31) — Income Tax Payable: 57831.00
LXEH income_statement (annual, 2022-12-31) — Interest Expense: 4014414.00
LXEH income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4014414.00
LXEH income_statement (annual, 2022-12-31) — Interest Income: 73705.00
LXEH income_statement (annual, 2022-12-31) — Interest Income Non Operating: 73705.00
LXEH cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 2615402.00
LXEH balance_sheet (annual, 2022-12-31) — Interest Payable: 387434.00
LXEH balance_sheet (annual, 2022-12-31) — Inventory: 1163776.00
LXEH balance_sheet (annual, 2022-12-31) — Invested Capital: 317692136.00
LXEH cash_flow (annual, 2022-12-31) — Investing Cash Flow: -456381.00
LXEH cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
LXEH cash_flow (annual, 2022-12-31) — Issuance Of Debt: 104250000.00
LXEH balance_sheet (annual, 2022-12-31) — Leases: 6637234.00
LXEH balance_sheet (annual, 2022-12-31) — Liabilities Heldfor Sale Non Current: 356250.00
LXEH balance_sheet (annual, 2022-12-31) — Line Of Credit: 61000000.00
LXEH balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3558380.00
LXEH balance_sheet (annual, 2022-12-31) — Long Term Debt: 1250000.00
LXEH balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4808380.00
LXEH cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 3750000.00
LXEH cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
LXEH balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 6484156.00
LXEH balance_sheet (annual, 2022-12-31) — Minority Interest: 548631.00
LXEH income_statement (annual, 2022-12-31) — Minority Interests: 301369.00
LXEH cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 156459.00
LXEH cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
LXEH income_statement (annual, 2022-12-31) — Net Income: -7789861.00
LXEH income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -7789861.00
LXEH income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -9919769.00
LXEH income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 1828539.00
LXEH income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -7789861.00
LXEH income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -9618400.00
LXEH cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -9919769.00
LXEH income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -8091230.00
LXEH cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
LXEH income_statement (annual, 2022-12-31) — Net Interest Income: -3940709.00
LXEH cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
LXEH cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -12250000.00
LXEH cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 3750000.00
LXEH income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -3940709.00
LXEH cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 850000.00
LXEH balance_sheet (annual, 2022-12-31) — Net PPE: 167689645.00
LXEH cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1296464.00
LXEH cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -16000000.00
LXEH balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 146532710.00
LXEH balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 2903456.00
LXEH balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2903456.00
LXEH income_statement (annual, 2022-12-31) — Normalized EBITDA: 1748651.00
LXEH income_statement (annual, 2022-12-31) — Normalized Income: -12624400.00
LXEH cash_flow (annual, 2022-12-31) — Operating Cash Flow: 40967701.00
LXEH income_statement (annual, 2022-12-31) — Operating Income: -26777397.00
LXEH income_statement (annual, 2022-12-31) — Operating Revenue: 41353741.00
LXEH balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 66667000.00
LXEH balance_sheet (annual, 2022-12-31) — Other Current Assets: 190238.00
LXEH balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2500000.00
LXEH balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 15476857.00
LXEH balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 65716190.00
LXEH income_statement (annual, 2022-12-31) — Other Gand A: 27664531.00
LXEH income_statement (annual, 2022-12-31) — Other Income Expense: 20846728.00
LXEH balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 36039589.00
LXEH cash_flow (annual, 2022-12-31) — Other Non Cash Items: -22850000.00
LXEH balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2369839.00
LXEH income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 16838728.00
LXEH balance_sheet (annual, 2022-12-31) — Other Payable: 13395255.00
LXEH balance_sheet (annual, 2022-12-31) — Other Properties: 7580536.00
LXEH balance_sheet (annual, 2022-12-31) — Other Receivables: 24640939.00
LXEH balance_sheet (annual, 2022-12-31) — Payables: 40675918.00
LXEH balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 41550812.00
LXEH balance_sheet (annual, 2022-12-31) — Prepaid Assets: 47056848.00
LXEH income_statement (annual, 2022-12-31) — Pretax Income: -9871378.00
LXEH balance_sheet (annual, 2022-12-31) — Properties: 0.00
LXEH income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 0.00
LXEH cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
LXEH cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
LXEH cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: 0.00
LXEH cash_flow (annual, 2022-12-31) — Purchase Of Investment: -9000000.00